Deprecated: Use of MediaWiki\Output\OutputPage::setIndexPolicy with index after noindex was deprecated in MediaWiki 1.43. [Called from MediaWiki\Output\OutputPage::setRobotPolicy in /home/forge/wikitrademarks.org/includes/Output/OutputPage.php at line 1008] in /home/forge/wikitrademarks.org/includes/debug/MWDebug.php on line 385
Category:Yongbin LIU of Houston TX (US) - WikiTrademarks Jump to content

Category:Yongbin LIU of Houston TX (US)

From WikiTrademarks
Revision as of 07:13, 18 July 2024 by Unknown user (talk) (Updating Category:Yongbin_LIU_of_Houston_TX_(US))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Yongbin LIU of Houston TX (US)

Executive Summary

Yongbin LIU of Houston TX (US) is an inventor who has filed 1 patents. Their primary areas of innovation include MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS (1 patents), Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca (1 patents), Antineoplastic agents (1 patents), and they have worked with companies such as THE METHODIST HOSPITAL SYSTEM (1 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations).

Patent Filing Activity

File:Yongbin LIU of Houston TX (US) Monthly Patent Applications.png

Technology Areas

File:Yongbin LIU of Houston TX (US) Top Technology Areas.png

List of Technology Areas

  • C08G69/10 (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS): 1 patents
  • A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents
  • A61P35/00 (Antineoplastic agents): 1 patents

Companies

File:Yongbin LIU of Houston TX (US) Top Companies.png

List of Companies

  • THE METHODIST HOSPITAL SYSTEM: 1 patents

Collaborators

Subcategories

This category has the following 3 subcategories, out of 3 total.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.